[Therapy of bacterial infections in infants and children. Report of 171 cases treated with trimethoprim-sulfamethoxazol].
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004357:Drug Synergism; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D005492:Folic Acid / Q000096:biosynthesis; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006192:Haemophilus Infections / Q000188:drug therapy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy*; D007408:Intestinal Absorption; D010033:Otitis Media / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D012480:Salmonella Infections / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D012874:Skin Diseases, Infectious / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D005492:Folic Acid; D013420:Sulfamethoxazole
Therapie bakterieller Infektionen bei Säuglingen und Kindern. Bericht über 171 Behandlungsfälle mit Trimethoprim-Sulfamethoxazol.